Logo image of 1ALB.MI

ALBEMARLE CORP (1ALB.MI) Stock Fundamental Analysis

BIT:1ALB - US0126531013 - Common Stock

67.66 EUR
+67.66 (+Infinity%)
Last: 8/20/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, 1ALB scores 3 out of 10 in our fundamental rating. 1ALB was compared to 69 industry peers in the Chemicals industry. While 1ALB seems to be doing ok healthwise, there are quite some concerns on its profitability. 1ALB is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

1ALB had negative earnings in the past year.
In the past year 1ALB had a positive cash flow from operations.
Of the past 5 years 1ALB 4 years were profitable.
In the past 5 years 1ALB always reported a positive cash flow from operatings.
1ALB.MI Yearly Net Income VS EBIT VS OCF VS FCF1ALB.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

With a Return On Assets value of -6.34%, 1ALB is not doing good in the industry: 75.36% of the companies in the same industry are doing better.
1ALB has a worse Return On Equity (-10.70%) than 73.91% of its industry peers.
Industry RankSector Rank
ROA -6.34%
ROE -10.7%
ROIC N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
1ALB.MI Yearly ROA, ROE, ROIC1ALB.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

1ALB has a Gross Margin of 7.76%. This is amonst the worse of the industry: 1ALB underperforms 84.06% of its industry peers.
In the last couple of years the Gross Margin of 1ALB has declined.
1ALB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
1ALB.MI Yearly Profit, Operating, Gross Margins1ALB.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

1ALB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 1ALB remains at a similar level compared to 1 year ago.
The number of shares outstanding for 1ALB has been increased compared to 5 years ago.
Compared to 1 year ago, 1ALB has an improved debt to assets ratio.
1ALB.MI Yearly Shares Outstanding1ALB.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
1ALB.MI Yearly Total Debt VS Total Assets1ALB.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

1ALB has an Altman-Z score of 1.65. This is a bad value and indicates that 1ALB is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.65, 1ALB is not doing good in the industry: 69.57% of the companies in the same industry are doing better.
1ALB has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.31, 1ALB is in the better half of the industry, outperforming 69.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 1.65
ROIC/WACCN/A
WACC8.09%
1ALB.MI Yearly LT Debt VS Equity VS FCF1ALB.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

1ALB has a Current Ratio of 2.31. This indicates that 1ALB is financially healthy and has no problem in meeting its short term obligations.
1ALB has a better Current ratio (2.31) than 75.36% of its industry peers.
1ALB has a Quick Ratio of 1.47. This is a normal value and indicates that 1ALB is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of 1ALB (1.47) is better than 72.46% of its industry peers.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 1.47
1ALB.MI Yearly Current Assets VS Current Liabilites1ALB.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for 1ALB have decreased strongly by -155.42% in the last year.
The Revenue for 1ALB has decreased by -33.05% in the past year. This is quite bad
Measured over the past years, 1ALB shows a quite strong growth in Revenue. The Revenue has been growing by 8.42% on average per year.
EPS 1Y (TTM)-155.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
Revenue 1Y (TTM)-33.05%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-7.02%

3.2 Future

The Earnings Per Share is expected to grow by 63.36% on average over the next years. This is a very strong growth
Based on estimates for the next years, 1ALB will show a quite strong growth in Revenue. The Revenue will grow by 11.24% on average per year.
EPS Next Y29.4%
EPS Next 2Y44.61%
EPS Next 3Y56.79%
EPS Next 5Y63.36%
Revenue Next Year-9.94%
Revenue Next 2Y-1.64%
Revenue Next 3Y4.19%
Revenue Next 5Y11.24%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1ALB.MI Yearly Revenue VS Estimates1ALB.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
1ALB.MI Yearly EPS VS Estimates1ALB.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for 1ALB. In the last year negative earnings were reported.
1ALB is valuated quite expensively with a Price/Forward Earnings ratio of 371.17.
Based on the Price/Forward Earnings ratio, 1ALB is valued a bit more expensive than the industry average as 69.57% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.63, 1ALB is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 371.17
1ALB.MI Price Earnings VS Forward Price Earnings1ALB.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ALB indicates a slightly more expensive valuation: 1ALB is more expensive than 71.01% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.11
1ALB.MI Per share data1ALB.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ALB does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as 1ALB's earnings are expected to grow with 56.79% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.61%
EPS Next 3Y56.79%

More info and screens

4

5. Dividend

5.1 Amount

1ALB has a Yearly Dividend Yield of 2.05%.
Compared to an average industry Dividend Yield of 3.06, 1ALB has a dividend in line with its industry peers.
1ALB's Dividend Yield is comparable with the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 2.05%

5.2 History

The dividend of 1ALB is nicely growing with an annual growth rate of 13.04%!
Dividend Growth(5Y)13.04%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

The earnings of 1ALB are negative and hence is the payout ratio. 1ALB will probably not be able to sustain this dividend level.
1ALB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-32.53%
EPS Next 2Y44.61%
EPS Next 3Y56.79%
1ALB.MI Yearly Income VS Free CF VS Dividend1ALB.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

More info and screens

ALBEMARLE CORP

BIT:1ALB (8/20/2025, 7:00:00 PM)

67.66

+67.66 (+Infinity%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners98.79%
Inst Owner ChangeN/A
Ins Owners0.36%
Ins Owner ChangeN/A
Market Cap7.96B
Analysts67.5
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.05%
Yearly Dividend2.28
Dividend Growth(5Y)13.04%
DP-32.53%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)91.46%
Min EPS beat(2)69.72%
Max EPS beat(2)113.21%
EPS beat(4)2
Avg EPS beat(4)-30.22%
Min EPS beat(4)-249.28%
Max EPS beat(4)113.21%
EPS beat(8)3
Avg EPS beat(8)-20.6%
EPS beat(12)7
Avg EPS beat(12)-3.87%
EPS beat(16)11
Avg EPS beat(16)2.43%
Revenue beat(2)1
Avg Revenue beat(2)0.26%
Min Revenue beat(2)-7.88%
Max Revenue beat(2)8.39%
Revenue beat(4)1
Avg Revenue beat(4)-2.61%
Min Revenue beat(4)-8.69%
Max Revenue beat(4)8.39%
Revenue beat(8)4
Avg Revenue beat(8)-0.47%
Revenue beat(12)4
Avg Revenue beat(12)-1.94%
Revenue beat(16)6
Avg Revenue beat(16)-0.69%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 371.17
P/S 1.87
P/FCF N/A
P/OCF 11.95
P/B 0.91
P/tB 1.12
EV/EBITDA 26.11
EPS(TTM)-2.32
EYN/A
EPS(NY)0.18
Fwd EY0.27%
FCF(TTM)-1.32
FCFYN/A
OCF(TTM)5.66
OCFY8.37%
SpS36.28
BVpS74.4
TBVpS60.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.34%
ROE -10.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.76%
FCFM N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 7.46
Cap/Depr 146.27%
Cap/Sales 19.25%
Interest Coverage N/A
Cash Conversion 182.86%
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 1.47
Altman-Z 1.65
F-Score4
WACC8.09%
ROIC/WACCN/A
Cap/Depr(3y)401.9%
Cap/Depr(5y)389.55%
Cap/Sales(3y)23.64%
Cap/Sales(5y)25.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-155.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
EPS Next Y29.4%
EPS Next 2Y44.61%
EPS Next 3Y56.79%
EPS Next 5Y63.36%
Revenue 1Y (TTM)-33.05%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-7.02%
Revenue Next Year-9.94%
Revenue Next 2Y-1.64%
Revenue Next 3Y4.19%
Revenue Next 5Y11.24%
EBIT growth 1Y79.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year157.47%
EBIT Next 3Y43.09%
EBIT Next 5Y36.66%
FCF growth 1Y-118.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.5%
OCF growth 3Y26.81%
OCF growth 5Y-0.49%